Krolick M A, Cintron G B
Department of Internal Medicine University of South Florida, College of Medicine, Tampa.
South Med J. 1991 May;84(5):670-1.
Bleeding is the most serious complication of thrombolytic therapy and limits its usefulness. We have reported a case of epidural hematoma, a rare occurrence after combined therapy with tissue plasminogen activator (TPA) and heparin. We emphasize that in patients treated with thrombolytic agents, any trauma may increase the risk of bleeding. The sudden onset of back pain and neurologic deficits should alert the clinician to the possibility of spinal hematoma with cord compression.
出血是溶栓治疗最严重的并发症,限制了其应用。我们报告了1例硬膜外血肿病例,这是组织纤溶酶原激活剂(TPA)与肝素联合治疗后罕见的情况。我们强调,在接受溶栓药物治疗的患者中,任何创伤都可能增加出血风险。背痛和神经功能缺损的突然出现应提醒临床医生注意脊髓受压导致脊髓血肿的可能性。